Bobbie J Rimel Selected Research

Ovarian Neoplasms (Ovarian Cancer)

2/2024	Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting.
11/2022	Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects.
1/2021	Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.
1/2019	Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
12/2016	Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bobbie J Rimel Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 12/2016
5	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 12/2016
3	Endometrial Neoplasms (Endometrial Cancer) 12/2023 - 10/2019
2	Disease Progression 07/2022 - 01/2019
1	Fatigue 12/2023
1	Hypertension (High Blood Pressure) 12/2023
1	Diarrhea 12/2023
1	Carcinoma (Carcinomatosis) 01/2021
1	Neutropenia 12/2016
1	Thrombocytopenia (Thrombopenia) 12/2016
1	Anemia 12/2016
1	Breast Neoplasms (Breast Cancer) 12/2014

Drug/Important Bio-Agent (IBA)

4	PlatinumIBA 11/2022 - 12/2016
3	niraparibIBA 11/2022 - 12/2016
2	Adenosine Diphosphate (ADP)IBA 02/2024 - 12/2016
2	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 02/2024 - 12/2016
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 01/2019
2	pembrolizumabIBA 01/2023 - 01/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 02/2024
1	olaparibIBA 12/2023
1	cediranib (AZD2171)IBA 12/2023
1	lenvatinibIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	hydrogen sulfite (bisulfite)IBA 07/2022
1	Gemcitabine FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2016

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 12/2023 - 01/2019
4	Therapeutics 01/2023 - 12/2016
1	Drug Tapering 01/2023
1	Hysterectomy 10/2019
1	Ovariectomy (Oophorectomy) 10/2019
1	Prophylactic Mastectomy 12/2014
1	Mastectomy (Mammectomy) 12/2014